ReviewCancer immunology, immunotherapy : CII2008

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.

Natalia Aptsiauri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.